Skip to content

A pilot clinical trial on effect of short term oral iron supplementation on Hb, ferritin, fatigue level, oxygen saturation in anemic university students

A pilot clinical trial on effect of short term oral iron supplementation on Hb, ferritin, fatigue level, oxygen saturation in anemic university students

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260621001
Enrollment
58
Registered
2026-06-21
Start date
2026-04-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia Iron-Deficiency Anemia Iron Dietary Supplements Ferritins Hemoglobins Fatigue

Interventions

Participants receive oral iron supplementation containing 10 to 15 mL orally twice daily for 4 weeks to improve hemoglobin, serum ferritin, fatigue level, and oxygen saturation.,Participants receive
Oral Iron Supplementation (Organic Iron Supplement),Standard Dietary Counseling

Sponsors

Imran Ahmad Khan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. University students aged 18 to 30 years with hemoglobin below WHO criteria 2. Participants with serum ferritin less than 30 ug/L 3. Participants with Fatigue Severity Scale score greater than or equal to 4, 4. Participants with their peripheral blood smear showing hypochromic microcytic anemia with pencil shaped red blood cells.

Exclusion criteria

Exclusion criteria: 1. Participants with severe anemia, thalassemia, sickle cell anemia 2. Participants with chronic kidney disease, chronic liver disease, malignancy, acute infection 3. Participants with inflammatory disease 4. Participants who have pregnancy 5. Lactating Females 6. Participants with recent iron therapy within the last 3 months, vitamin B12 deficiency, folate deficiency 7. Participants with gastrointestinal malabsorption disorders, known allergy to oral iron supplementation 8. Participants who were unwilling to participate were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Hemoglobin Baseline and 4 weeks post intervention Measured in g/dL using automated hematology analyzer (Complete Blood Count),Serum Ferritin Baseline and 4 weeks post intervention Measured using ELISA ,Fatigue Severity Scale score Baseline and 8 weeks post intervention 9-item Fatigue Severity Scale (FSS), mean score calculated ,Oxygen Saturation Baseline and 4 weeks post intervention Measured in percentage (%) using fingertip pulse oximeter

Secondary

MeasureTime frame
Clinical Symptoms of Anemia Baseline and 4 weeks post intervention tructured questionnaire assessing fatigue related symptoms such as weakness, dizziness, and poor concentration,Complete Blood Count Parameters Baseline and 4 weeks post intervention RBC count using automated hematology analyzer,Peripheral Blood Smear Morphology Baseline and 4 weeks post intervention Examination of peripheral blood smear slides using light microscopy to assess red blood cell morphology including hypochromia, microcytosis and pencil shaped red blood cells (elliptocytes),Respiration rate Baseline and 4 weeks post intervention Measured in breaths per minute using standard clinical observation method

Countries

Pakistan

Contacts

Public ContactMaliha Khan

Muhammad Nawaz Sharif University of Agriculture Multan

malihatareen1997@gmail.com03126827130

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026